Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer's disease.
Xinwen ZhangRihua WangDi HuXiaoyan SunHisashi FujiokaKathleen LundbergErnest Ricky ChanQuanqiu WangRong XuMargaret E FlanaganAndrew A PieperXin QiPublished in: Science advances (2020)
Myelin degeneration and white matter loss resulting from oligodendrocyte (OL) death are early events in Alzheimer's disease (AD) that lead to cognitive deficits; however, the underlying mechanism remains unknown. Here, we find that mature OLs in both AD patients and an AD mouse model undergo NLR family pyrin domain containing 3 (NLRP3)-dependent Gasdermin D-associated inflammatory injury, concomitant with demyelination and axonal degeneration. The mature OL-specific knockdown of dynamin-related protein 1 (Drp1; a mitochondrial fission guanosine triphosphatase) abolishes NLRP3 inflammasome activation, corrects myelin loss, and improves cognitive ability in AD mice. Drp1 hyperactivation in mature OLs induces a glycolytic defect in AD models by inhibiting hexokinase 1 (HK1; a mitochondrial enzyme that initiates glycolysis), which triggers NLRP3-associated inflammation. These findings suggest that OL glycolytic deficiency plays a causal role in AD development. The Drp1-HK1-NLRP3 signaling axis may be a key mechanism and therapeutic target for white matter degeneration in AD.
Keyphrases
- white matter
- nlrp inflammasome
- oxidative stress
- mouse model
- end stage renal disease
- multiple sclerosis
- ejection fraction
- chronic kidney disease
- signaling pathway
- peritoneal dialysis
- skeletal muscle
- type diabetes
- adipose tissue
- patient reported outcomes
- endothelial cells
- optical coherence tomography
- replacement therapy
- stress induced
- wild type
- neural stem cells